Hitiq Limited Stock: price and insider trades · Australia

Hitiq Limited belongs to the Health Care sector. Filings by its managers are published through ASX. 6 insiders have disclosed 11 filings since 18 October 2025.

No insider sold shares on the market over the period. Instead, the filings list 6 purchases totalling €3,416, made by 2 insiders. The totals exclude 4 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €3,416, bought and made public on 16 July 2026. Among those who bought: 2 senior executives.

With 11 filings in twelve months, the company is more active than the median of 3 filings across the 2,222 companies we follow on the same exchange. Our records for Hitiq Limited go back to 2026, with 6 purchases and no sales on the open market in total.

The last insider purchase was made public on 17 September 2026, 31 days ago. Between a trade and the moment it shows up on ASX, the median delay is 7 days. This delay matters because a trade only becomes useful information once it is public.

For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. This summary is built from ASX disclosures alone and does not predict where the share price will go.